Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015.

Published

Journal Article

In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2015. This schedule provides a summary of ACIP recommendations for the use of vaccines routinely recommended for adults aged 19 years or older in two figures, footnotes for each vaccine, and a table that describes primary contraindications and precautions for commonly used vaccines for adults. Changes in the 2015 adult immunization schedule from the 2014 schedule included the August 2014 recommendation for routine administration of the 13-valent pneumococcal conjugate vaccine (PCV13) in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older, the August 2014 revision on contraindications and precautions for the live attenuated influenza vaccine (LAIV), and the October 2014 approval by the Food and Drug Administration to expand the approved age for use of recombinant influenza vaccine (RIV). These revisions were also reviewed and approved by the American College of Physicians, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and American College of Nurse-Midwives.

Full Text

Duke Authors

Cited Authors

  • Kim, DK; Bridges, CB; Harriman, KH; Centers for Disease Control and Prevention (CDC), ; Advisory Committee on Immunization Practices (ACIP), ; ACIP Adult Immunization Work Group,

Published Date

  • February 6, 2015

Published In

Volume / Issue

  • 64 / 4

Start / End Page

  • 91 - 92

PubMed ID

  • 25654609

Pubmed Central ID

  • 25654609

Electronic International Standard Serial Number (EISSN)

  • 1545-861X

Language

  • eng

Conference Location

  • United States